Guidelines, recommendations, descriptions
Full list in chronological order
12 December 2008
Addressing ethical issues in pandemic influenza planning
DISCUSSION PAPERS
12 September 2008
Availability of new recombinant H5N1 vaccine virus
6 September 2008
Early recognition, reporting and infection control management of acute respiratory diseases of potential international concern
13 August 2008
Infection control recommendations for avian influenza in health-care facilities
16 May 2008
Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile
WHO Scientific Consultation
Geneva, Switzerland, 1-3 October 2007
18 February 2008
Protection of individuals with high poultry contact in areas affected by avian influenza H5N1: Consolidation of pre-existing guidance
February 2008
20 December 2007
Ethical considerations in developing a public health response to pandemic influenza
16 October 2007
WHO accepts positive PCR test results of H5 infection in humans from the following laboratories
November 2008
16 October 2007
WHO Interim Protocol: Rapid operations to contain the initial emergence of pandemic influenza
Updated October 2007
4 September 2007
Recommendations and laboratory procedures for detection of avian influenza A(H5N1) virus in specimens from suspected human cases
Revised August 2007
30 August 2007
WHO criteria for accepting positive PCR test results of H5 infection in humans from national reference laboratories
Amendment 30 August 2007
15 August 2007
Clinical management of human infection with avian influenza A (H5N1) virus
15 August 2007
7 August 2007
Towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses
15 May 2007
The role of National Influenza Centres (NICs) during interpandemic, pandemic alert and pandemic periods
Interim Document, May 2007
15 May 2007
WHO External Quality Assessment Project for the Detection of Subtype Influenza A Viruses by PCR
July 2007
14 May 2007
Global consultation on addressing ethical issues in pandemic influenza planning
Summary of discussions,
24-25 October 2006, Geneva, Switzerland
5 April 2007
Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as human vaccines
9 February 2007
Update: WHO-confirmed human cases of avian influenza A(H5N1) infection, 25 November 2003 – 24 November 2006
Weekly Epidemiological Record (WER) vol. 82, 6 (pp 41–48)
1 February 2007
Early release of influenza viruses for pandemic influenza vaccine development
21 December 2006
Availability of new recombinant H5N1 vaccine virus
27 November 2006
WHO guidelines for investigation of human cases of avian influenza A(H5N1)
January 2007
6 November 2006
Collecting, preserving and shipping specimens for the diagnosis of avian influenza A(H5N1) virus infection.
Guide for field operations
October 2006
2 November 2006
Influenza research at the human and animal interface
Report of a WHO working group
Geneva, Switzerland, 21-22 September 2006
27 October 2006
Human cases of influenza A(H5N1) infection, in eastern Turkey, December 2005–January 2006
27 October 2006, Weekly Epidemiological Record (WER) vol. 81, 43 (p 410)
23 October 2006
Global pandemic influenza action plan to increase vaccine supply
16 October 2006
WHO strategic action plan for pandemic influenza
29 August 2006
WHO case definitions for human infections with influenza A(H5N1) virus
23 August 2006
WHO procedures for obtaining release of H5N1 sequences to the public domain
30 June 2006
Epidemiology of WHO-confirmed human cases of avian A(H5N1) infection
30 June 2006, Weekly Epidemiological Record (WER) vol. 81, 26 (pp 249–260)
28 June 2006
Availability of new H5N1 prototype strain for influenza pandemic vaccine development
June 2006
25 May 2006
Availability of new H5N1 prototype strain for influenza pandemic vaccine development
May 2006
19 May 2006
Maintaining a Safe and Adequate Blood Supply in the Event of Pandemic Influenza
19 May 2006
WHO Rapid Advice Guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus
5 May 2006
Human avian influenza in Azerbaijan, February–March 2006
5 May 2006, Weekly Epidemiological Record (WER) vol. 81, 18 (pp 173–188)
7 April 2006
Pandemic influenza preparedness and mitigation in refugee and displaced populations
WHO guidelines for humanitarian agencies
26 March 2006
WHO/ISIRV/FIND Consultation on Diagnosis of H5N1 Avian Influenza Infections in Humans
19-20 February 2007
3 March 2006
Availability of new H5N1 prototype strain for influenza pandemic vaccine development
March 2006
20 February 2006
Avian influenza: significance of mutations in the H5N1 virus
13 February 2006
Avian influenza, including influenza A (H5N1), in humans: WHO interim infection control guideline for health care facilities
Revised 10 May 2007
28 October 2005
WHO recommended H5N1 prototype strains for influenza pandemic vaccine development remain the same
28 October 2005
26 October 2005
WHO guidance on public health measures in countries experiencing their first outbreaks of H5N1 avian influenza
October 2005
5 September 2005
Responding to the avian influenza pandemic threat.
Recommended strategic actions
2 September 2005
12 August 2005
H5N1 avian influenza – first steps towards development of a human vaccine
12 August 2005
20 July 2005
Available evidence suggests no need to change the WHO recommended influenza A/H5N1 vaccine prototype strains
20 July 2005
13 June 2005
WHO intercountry-consultation. Influenza A/H5N1 in humans in Asia. Manila, Philippines, 6-7 May 2005
May 2005
13 June 2005
WHO recommendations on the use of rapid testing for influenza diagnosis
July 2005
16 April 2005
Access to influenza A(H5N1) viruses
April 2005
8 April 2005
WHO global influenza preparedness plan
The role of WHO and recommendations for national measures before and during pandemics - March 2005
Update November 2005 - Clarification on the use of masks by health-care workers in pandemic settings
1 March 2005
WHO checklist for influenza pandemic preparedness planning
2005
7 February 2005
Availability of H5N1 prototype strains for influenza pandemic vaccine development
February 2005
25 January 2005
Avian influenza: assessing the pandemic threat
January 2005
12 January 2005
WHO guidelines for the storage and transport of human and animal specimens for laboratory diagnosis of suspected avian influenza A infection
12 January 2005
12 January 2005
WHO laboratory biosafety guidelines for handling specimens suspected of containing avian influenza A virus
12 January 2005
12 January 2005
WHO laboratory guidelines for the collection of animal specimens for diagnosis of influenza infection
12 January 2005
23 April 2004
WHO consultation on priority public health interventions before and during an influenza pandemic
27 April 2004
17 February 2004
Avian influenza A(H5N1) - Report in the Weekly Epidemiological Record, vol 79, 7 (pp65-70)
13 February 2004
16 February 2004
Advice for people living in areas affected by bird flu or avian influenza
8 November 2004
12 February 2004
Preliminary clinical and epidemiological description of influenza A (H5N1) in Viet Nam
12 February 2004
12 February 2004
Avian influenza A(H5) in rural areas in Asia: food safety considerations
10 February 2004
WHO guidelines for global surveillance of influenza A/H5
6 February 2004
6 February 2004
WHO guidelines for the collection of human specimens for laboratory diagnosis of avian influenza infection
12 January 2005
6 February 2004
WHO reference laboratories for diagnosis of influenza A/H5 infection
20 February 2008
2 February 2004
WHO interim recommendations for the protection of persons involved in the mass slaughter of animals potentially infected with highly pathogenic influenza viruses
January 2004
30 January 2004
Guidelines for the use of seasonal influenza vaccine in humans at risk of H5N1 infection
30 January 2004
25 November 2003
Production of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses. Interim biosafety risk assessment.
November 2003
|
